PE79799A1 - Forma cristalina de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida - Google Patents

Forma cristalina de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida

Info

Publication number
PE79799A1
PE79799A1 PE1998000478A PE00047898A PE79799A1 PE 79799 A1 PE79799 A1 PE 79799A1 PE 1998000478 A PE1998000478 A PE 1998000478A PE 00047898 A PE00047898 A PE 00047898A PE 79799 A1 PE79799 A1 PE 79799A1
Authority
PE
Peru
Prior art keywords
difluorbencil
carboxamide
triazole
compound
crystalline forms
Prior art date
Application number
PE1998000478A
Other languages
English (en)
Spanish (es)
Inventor
Andreas Burkhard
Robert Portmann
Urs Christoph Hofmeier
Walter Scherrer
Martin Szelagiewicz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE79799(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE79799A1 publication Critical patent/PE79799A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PE1998000478A 1997-06-10 1998-06-08 Forma cristalina de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida PE79799A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10

Publications (1)

Publication Number Publication Date
PE79799A1 true PE79799A1 (es) 1999-09-03

Family

ID=4209650

Family Applications (2)

Application Number Title Priority Date Filing Date
PE1998000478A PE79799A1 (es) 1997-06-10 1998-06-08 Forma cristalina de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida
PE1998000479A PE80999A1 (es) 1997-06-10 1998-06-08 Forma cristalina de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE1998000479A PE80999A1 (es) 1997-06-10 1998-06-08 Forma cristalina de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida

Country Status (36)

Country Link
US (6) US6740669B1 (enExample)
EP (2) EP0994864B1 (enExample)
JP (2) JP3672574B2 (enExample)
KR (2) KR100425656B1 (enExample)
CN (3) CN1298708C (enExample)
AR (4) AR012946A1 (enExample)
AT (2) ATE232852T1 (enExample)
AU (2) AU725517B2 (enExample)
BR (2) BR9804947A (enExample)
CA (3) CA2256013C (enExample)
CO (2) CO4940452A1 (enExample)
CY (1) CY2007014I1 (enExample)
CZ (2) CZ292260B6 (enExample)
DE (3) DE69811500T2 (enExample)
DK (2) DK0994863T3 (enExample)
ES (2) ES2197485T3 (enExample)
FR (1) FR07C0037I2 (enExample)
HU (2) HU226107B1 (enExample)
ID (2) ID21014A (enExample)
IL (2) IL125732A (enExample)
LU (1) LU91345I2 (enExample)
MY (2) MY120156A (enExample)
NL (1) NL300284I2 (enExample)
NO (2) NO329315B1 (enExample)
NZ (2) NZ331371A (enExample)
PE (2) PE79799A1 (enExample)
PL (2) PL192114B1 (enExample)
PT (1) PT994864E (enExample)
RU (2) RU2194041C2 (enExample)
SI (2) SI0994864T1 (enExample)
SK (2) SK283685B6 (enExample)
TR (2) TR199801630T1 (enExample)
TW (2) TW403740B (enExample)
UY (1) UY25844A1 (enExample)
WO (2) WO1998056772A1 (enExample)
ZA (2) ZA984966B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
PE20040538A1 (es) * 2002-05-31 2004-08-30 Schering Corp Polimorfos inhibidores de xantina fosfodiesterasa v
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
NZ591725A (en) * 2008-10-13 2012-09-28 Cipla Ltd PROCESS FOR THE PREPARATION OF RUFINAMIDE which is also known as 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
US8377973B2 (en) * 2009-09-04 2013-02-19 Tactical Therapeutics Inc Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
EP2465853A1 (en) * 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorph of rufinamide and process for obtaining it
WO2011135105A1 (en) * 2010-04-30 2011-11-03 Laboratorios Lesvi, S.L. Improved process for preparing rufinamide intermediate
ITMI20110718A1 (it) 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
US10206874B2 (en) 2012-07-20 2019-02-19 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
FI834666A7 (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
PH22568A (en) * 1985-04-18 1988-10-17 Ciba Geigy Ag Fluorinated benzyl triazoles and pharmaceutical compositions containing the same
CA2002864C (en) 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
JPH04506967A (ja) 1989-07-27 1992-12-03 ジー．ディー．サール　アンド　カンパニー 高血圧症治療用腎選択性生成物
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
AU656154B2 (en) 1990-11-06 1995-01-27 Astellas Pharma Inc. Fused pyrazine derivative
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
CN1072215C (zh) 1995-02-22 2001-10-03 赫彻斯特药品和化学品公司 无定形吡咯他尼、吡咯他尼多晶型物,其制备方法和用途
SK283990B6 (sk) * 1996-07-11 2004-07-07 Novartis Ag Spôsob prípravy 1-substituovaných 4-kyano-1,2,3-triazolov, 4-kyano-1-(2,6-difluórbenzyl)-1H-1,2,3-triazol
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide

Also Published As

Publication number Publication date
CZ253398A3 (cs) 1999-04-14
KR19990087835A (ko) 1999-12-27
JP2000516259A (ja) 2000-12-05
US20060116520A1 (en) 2006-06-01
KR19990087836A (ko) 1999-12-27
NZ331371A (en) 2000-08-25
HK1028241A1 (en) 2001-02-09
ID21014A (id) 1999-04-08
DE69811500T2 (de) 2004-04-01
US7750028B2 (en) 2010-07-06
HK1028242A1 (en) 2001-02-09
AR061004A2 (es) 2008-07-30
DK0994864T3 (da) 2003-07-21
LU91345I2 (fr) 2007-09-04
SI0994863T1 (en) 2003-08-31
IL125733A0 (en) 1999-04-11
HUP0000798A3 (en) 2000-10-30
AR012946A1 (es) 2000-11-22
US20030125568A1 (en) 2003-07-03
CA2256013A1 (en) 1998-12-17
NO329315B1 (no) 2010-09-27
CN1132820C (zh) 2003-12-31
TW403740B (en) 2000-09-01
CY2007014I2 (el) 2009-11-04
ZA984967B (en) 1999-01-11
DE69811500D1 (de) 2003-03-27
WO1998056772A1 (en) 1998-12-17
NO329314B1 (no) 2010-09-27
CO4940448A1 (es) 2000-07-24
SK283685B6 (sk) 2003-12-02
FR07C0037I2 (enExample) 2008-05-16
TR199801631T1 (xx) 1999-06-21
MY125854A (en) 2006-08-30
US6740669B1 (en) 2004-05-25
US20040167186A1 (en) 2004-08-26
PL330764A1 (en) 1999-05-24
DE69813560T2 (de) 2004-02-05
ATE232852T1 (de) 2003-03-15
TW526195B (en) 2003-04-01
CA2256013C (en) 2007-10-16
SK283734B6 (sk) 2003-12-02
WO1998056773A1 (en) 1998-12-17
CA2614926A1 (en) 1998-12-17
NO983666L (no) 1998-12-17
NO983667L (no) 1998-12-17
ZA984966B (en) 1999-01-11
MY120156A (en) 2005-09-30
IL125732A (en) 2002-12-01
PL192114B1 (pl) 2006-08-31
NL300284I2 (nl) 2007-11-01
PL330798A1 (en) 1999-06-07
PL191943B1 (pl) 2006-07-31
EP0994864A1 (en) 2000-04-26
KR100409168B1 (ko) 2004-01-31
TR199801630T1 (xx) 1999-06-21
CN1217716A (zh) 1999-05-26
HK1028031A1 (en) 2001-02-02
CZ292481B6 (cs) 2003-09-17
JP3672574B2 (ja) 2005-07-20
CA2256015A1 (en) 1998-12-17
CN1159300C (zh) 2004-07-28
EP0994863B1 (en) 2003-02-19
SK109398A3 (en) 1998-12-02
JP2000516258A (ja) 2000-12-05
HU225153B1 (en) 2006-07-28
EP0994863A1 (en) 2000-04-26
HUP0002113A3 (en) 2002-09-30
AU8437198A (en) 1998-12-30
CY2007014I1 (el) 2009-11-04
KR100425656B1 (ko) 2004-05-17
HUP0000798A2 (hu) 2000-10-30
AU8437298A (en) 1998-12-30
ES2192779T3 (es) 2003-10-16
IL125732A0 (en) 1999-04-11
US20100310655A1 (en) 2010-12-09
AR012945A1 (es) 2000-11-22
CN1259127A (zh) 2000-07-05
HU226107B1 (en) 2008-04-28
RU2194041C2 (ru) 2002-12-10
US8076362B2 (en) 2011-12-13
DE69813560D1 (de) 2003-05-22
AU725528B2 (en) 2000-10-12
US20010037029A1 (en) 2001-11-01
ES2197485T3 (es) 2004-01-01
BR9804946A (pt) 1999-08-24
SI0994864T1 (en) 2003-10-31
LU91345I9 (enExample) 2018-12-31
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
US6455556B2 (en) 2002-09-24
FR07C0037I1 (enExample) 2007-08-17
SK109498A3 (en) 1998-12-02
JP3672575B2 (ja) 2005-07-20
CZ292260B6 (cs) 2003-08-13
HUP0002113A2 (hu) 2001-02-28
EP0994864B1 (en) 2003-04-16
CZ253498A3 (cs) 1999-04-14
ID27660A (id) 2001-04-19
CA2256015C (en) 2008-06-03
BR9804947A (pt) 1999-08-24
CN1298708C (zh) 2007-02-07
AR061005A2 (es) 2008-07-30
CA2614926C (en) 2010-02-09
PE80999A1 (es) 1999-09-06
RU2198167C2 (ru) 2003-02-10
NZ331370A (en) 2000-08-25
NO983666D0 (no) 1998-08-11
DK0994863T3 (da) 2003-05-26
IL125733A (en) 2002-12-01
UY25844A1 (es) 2001-08-27
CN1572789A (zh) 2005-02-02
PT994864E (pt) 2003-07-31
DE122007000051I1 (de) 2007-11-08
DE122007000051I2 (de) 2009-02-19
CO4940452A1 (es) 2000-07-24
AU725517B2 (en) 2000-10-12
ATE237599T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
PE79799A1 (es) Forma cristalina de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida
ES2150686T3 (es) Proceso para la preparacion de alcanos halogenados.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
ES2150567T3 (es) Antagonistas del factor de liberacion de la corticotropina.
CY1108101T1 (el) Ενωσεις πυριμιδινης και η χρηση τους στην παρασκευη ενος τριαζολο-πυριμιδιν καρβα νουκλεοζιτη
ATE246681T1 (de) Sulfonamide
CO5160257A1 (es) La n-piperidino-5-(4-bromofenil)-1-(2,4-diclorofenil)-4-etilpirazol-3-carboxamida, sus sales, su preparacion y las composiciones farmaceuticas que la contienen
DE3765045D1 (de) Fluorierte nucleoside, ihre herstellung und ihre pharmazeutische verwendung gegen aids.
SE9504661D0 (sv) New compounds
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
TR200201683T2 (tr) İkameli fenil-piperazin türevleri, bunların hazırlanması ve kullanımları
ES2123109T3 (es) Composicion de teñido de oxidacion para fibras queratinicas que comprenden un para-amino-fenol, un meta-amino-fenol y una meta-fenilen-diamina.
ES2191942T3 (es) Nueva utilizacion de un antagonista especifico de los receptores 5ht2a.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
DK0541594T3 (da) Cyklopentan-derivater, fremgangsmåde til fremstilling deraf samt farmaceutisk anvendelse af derivaterne
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
ES2193248T3 (es) Antraquinonas mono- y disulfosustituidas y su uso para el tratamiento de desordenes de la matriz osea.
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
TR199701298T1 (xx) Tetralinler.
ES2062138T3 (es) Utilizacion de 5'-deoxi-5'-metiltioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas favorecedoras del crecimiento del cabello en sujetos adolecientes de calvicie.
UY26224A1 (es) Complejo farmaceutico ley 17164 art. 127
FI924307A7 (fi) Tulehdusta estävien 1,5-diaryylipyratsolilääkeaineiden alueselektiivinen synteesi
TR199800904T2 (xx) Yeni kinoksalindiyon t�revleri'nin �retimi ve ila�larda kullan�m�
ITRM20000433A0 (it) Uso di fibrati per la preparazione di un medicamento utile nel trattamento dell'insufficenza cardiaca congestizia.

Legal Events

Date Code Title Description
FG Grant, registration
MK Expiration of term